These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4461789)

  • 21. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
    Karobath ME
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine and schizophrenia.
    Westerink BH; Korf J
    Lancet; 1976 Oct; 2(7988):749. PubMed ID: 61434
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 26. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 27. Antipsychotic drug doses and neuroleptic/dopamine receptors.
    Seeman P; Lee T; Chau-Wong M; Wong K
    Nature; 1976 Jun; 261(5562):717-9. PubMed ID: 945467
    [No Abstract]   [Full Text] [Related]  

  • 28. Schizophrenia.
    Morrison PD; Murray RM
    Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
    [No Abstract]   [Full Text] [Related]  

  • 29. New developments in the study of the mechanism of action of neuroleptics and amphetamine.
    Glowinski J
    J Psychiatr Res; 1974; 11():81-5. PubMed ID: 4156794
    [No Abstract]   [Full Text] [Related]  

  • 30. [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].
    Nielsen IM; Christensen AV; Hyttel J
    Arzneimittelforschung; 1976; 26(6):1090-2. PubMed ID: 989383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 33. The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor blockade.
    Rolls ET; Rolls BJ; Kelly PH; Shaw SG; Wood RJ; Dale R
    Psychopharmacologia; 1974; 38(3):219-30. PubMed ID: 4423729
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
    Jardemark K; Wadenberg ML; Grillner P; Svensson TH
    Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of schizophrenia.
    Ban TA
    Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain.
    Nybäck H; Schubert J; Sedvall G
    J Pharm Pharmacol; 1970 Aug; 22(8):622-4. PubMed ID: 4394540
    [No Abstract]   [Full Text] [Related]  

  • 37. Displacement of bound 14C-fluphenazine by biogenic amines and antipsychotic drugs in homogenates of brain tissue.
    Taylor KM
    Nature; 1974 Nov; 252(5480):238-41. PubMed ID: 4421701
    [No Abstract]   [Full Text] [Related]  

  • 38. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine and schizophrenia--proof at last?
    Harrison PJ
    Lancet; 2000 Sep; 356(9234):958-9. PubMed ID: 11041394
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4376-80. PubMed ID: 1060115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.